✦ LIBER ✦

4863727 Combination therapy using interleukin-2 and tumor necrosis factor

Book ID: 122950040
Publisher: Elsevier Science
Year: 1990
Tongue: English
Weight: 65 KB
Volume: 8
Category: Article
ISSN: 0734-9750
DOI: 10.1016/0734-9750(90)91519-M

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

5098702 Combination therapy using interl

5098702 Combination therapy using interleukin-2 and tumor necrosis factor

📂 Article 📅 1992 🏛 Elsevier Science 🌐 English ⚖ 68 KB

4894225 Combination therapy using antitu

4894225 Combination therapy using antitumor immunotoxins with tumor necrosis factor

✍ Goebel, S.; Bochan, M.; Brahmi, Z. 📂 Article 📅 1990 🏛 Elsevier Science 🌐 English ⚖ 60 KB

Combination tumor-immunotherapy with rec

Combination tumor-immunotherapy with recombinant tumor necrosis factor and recombinant interleukin 2 in mice

✍ Takashi Nishimura; So Ohta; Naoko Sato; Yuji Togashi; Makiko Goto; Yoshiyuki Has 📂 Article 📅 1987 🏛 John Wiley and Sons 🌐 French ⚖ 656 KB

Recombinant human tumor necrosis factor (r-TNF) inhibits growth of various mouse tumor cell lines both in vitro and in vivo. Treatment of established tumor nodules with intratumoral (i.t.) injection of r-TNF caused hemorrhagic necrosis of tumor and temporary disappearance of tumor mass. However, a s

Circulating soluble tumor necrosis facto

Circulating soluble tumor necrosis factor receptors, interleukin-2 receptors, tumor necrosis factor α, and interleukin-6 levels in rheumatoid arthritis.

✍ Pilar Barrera; Agnes M. Th. Boerbooms; Elly M. Janssen; Robert W. Sauerwein; H. 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 English ⚖ 839 KB

Rheumatoid arthritis therapy after tumor

Rheumatoid arthritis therapy after tumor necrosis factor and interleukin-1 blockade

✍ Kurt Redlich; Georg Schett; Günter Steiner; Silvia Hayer; Erwin F. Wagner; Josef 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 711 KB

With concomitant methotrexate. † Pegylated recombinant methionyl human soluble tumor necrosis factor type I.

5425940 Combination therapy using interl

5425940 Combination therapy using interleukin-2 and tumor necrosis factor : Zimmerman Robert; Winkelhake Jeffrey L Lafayette, CA, United States Assigned to Cetus Oncology Corporation

📂 Article 📅 1996 🏛 Elsevier Science 🌐 English ⚖ 61 KB